Efficacy of Cefoperazone/sulbactam on Severe Nosocomial Lower Respiratory Infection: A Clinical Analysis
- VernacularTitle:头孢哌酮/舒巴坦治疗重症下呼吸道医院感染的临床分析
- Author:
Xiaoxia WANG
;
Xuefeng ZENG
- Publication Type:Journal Article
- Keywords:
Cefoperazone/sulbactam;
Lower respiratory tract;
Nosocomial infections
- From:Chinese Journal of Nosocomiology
1994;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the clinical and bacterial efficacy and safety of cefoperazone/sulbactam(Sulperazone) on severe nosocomial lower respiratory infections. METHODS The clinical materials in the treatment of severe nosocomical lower respiratory infections from Mar 2002 to Mar 2005 were analyzed retrospectively. RESULTS The overall clinical efficacy rate of Sulperazone was 83.9%,the bacterial eradication rate was 92.%,The sensitivity rate to Sulperazone was 88.2%.There was no adverse reaction in the observation. CONCLUSIONS Sulperazone is effective and safe in the treatment of severe nosocomial lower respiratory infection.
